DNA Day: The Human Genome Project and Advancements in Biotechnology

womann in scrubs and gloves working with DNA equipment in a lab

Today, April 25, we are celebrating DNA Day - talking about one of the most significant advancements in the history of DNA - the completion of the Human Genome Project and how it has shaped the future of biotechnology. 

To help us break down this achievement in science and health care, we spoke with Ericka Hendrix, Ph.D., MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions. 

The Human Genome Project

The National Human Genome Research Institute describes The Human Genome Project (HGP) as one of the greatest scientific feats in history - a global scientific effort with a goal to generate the first sequence of the human genome.  

“The project was a voyage of biological discovery led by an international group of researchers looking to comprehensively study all of the DNA (known as a genome) of a select set of organisms,” according to the NIH. “Launched in October 1990 and completed in April 2003, the Human Genome Project’s signature accomplishment – generating the first sequence of the human genome – provided fundamental information about the human blueprint, which has since accelerated the study of human biology and improved the practice of medicine.”

Fast facts from the NIH:

  • In 2003, the Human Genome Project produced a genome sequence that accounted for over 90% of the human genome. It was as close to complete as the technologies for sequencing DNA allowed at the time.
  • Concerns and questions about sequencing the human genome helped to usher in a greater emphasis on ethics in biomedical research.
  • The project was atypical for biomedical research, in that the researchers’ work was driven by a desire to explore an unknown part of the biological world — as opposed to first formulating a theory or hypothesis.
  • The sequencing of the human genome involved researchers from 20 separate universities and research centers across the United States, United Kingdom, France, Germany, Japan and China.
Ericka Hendrix, Ph.D.

Ericka Hendrix, Ph.D.

Dr. Hendrix explains that this project was a unique change in research in that people began sharing data, starting a more open dialogue among researchers. This change, coupled with other scientific advancements and a global pandemic, have completely revolutionized the landscape of biotechnology today. 

“Now, we can sequence a human genome in just a few days in one lab,” says Hendrix. “This new tech is called next-generation sequencing that quickly and accurately provides more personalized medicine for patients. It’s realistic and doable to now sequence  whole genomes  to detect certain diseases.”

The Future of Biotechnology

Hendrix talks about the key areas that have been most impacted by the project and will only continue to shape biotechnology.

Treating inherited genetic diseases: Hendrix explains that DNA codes for how certain proteins are expressed in our bodies. She says this can be used to interpret risk assessment for certain diseases and recognize active diseases, but also allows care teams to treat patients appropriately.

“Right now, we can do a genetic cancer panel,” Hendrix says. “Molecular oncology is probably the second fastest growing part of our field today.”

Real-Time PCR: Polymerase Chain Reaction is commonly used to measure gene expression and is how scientists first detected COVID-19.

“It has given us the ability to detect microorganisms or viruses really quickly, and because of coronavirus testing, the area of rapid molecular testing for infectious diseases took off,” says Hendrix. “In the future, I think there will be a greater ability to provide the general public accessibility to rapid testing in a lot of different areas.”

Other relevant areas of advancement according to Hendrix include:

  • Identifying new pathogens and linking those to diseases
  • Gene therapy
  • Noninvasive prenatal testing and liquid biopsy testing for cancer 

As far as her predictions for what’s to come, Hendrix says that in the clinical space, there is still much more to learn regarding associations with genetic variations and diseases. She even mentions that there is a current push for sequencing every newborn baby, despite ethical questions raised with the topic.

A New Age

Ultimately, while Hendrix notes the accomplishment that the Human Genome Project was and still is today, she credits the COVID-19 pandemic for changing the perception and landscape of her field for generations to come.

“The COVID-19 pandemic really caused everyone to embrace what we do,” she says. “I train students to become molecular scientists, and we need to be able to have scientists that can pivot quickly, so that’s really our focus and our passion."

The goal, Hendrix says, is $1,000 genome. While science and technology isn’t there yet, the future is bright for this burgeoning field in health care. 


Related Stories


GMES: Explore Medicine without an M.D.

GMES is a two-year, non-thesis Master of Science degree offered at TTUHSC specifically designed for students with a goal to teach in the anatomical sciences or who want more preparation for medical school.


TTUHSC School of Medicine Faculty Member Elected to the Texas Medical Association Board of Trustees

The Texas Medical Association (TMA) elected Rodney Young, M.D., to the TMA Board of Trustees during TexMed 2024, its annual conference in Dallas.


TTUHSC and the Texas Suicide Prevention Collaborative to Present Summit

TTUHSC will collaborate with the Texas Suicide Prevention Collaborative to present the Texas Higher Education Suicide Prevention Spring Summit 8 a.m. to noon May 14. The free event will be virtual.

Recent Stories


TTUHSC School of Medicine Faculty Member Elected to the Texas Medical Association Board of Trustees

The Texas Medical Association (TMA) elected Rodney Young, M.D., to the TMA Board of Trustees during TexMed 2024, its annual conference in Dallas.


Texas Tech Physicians Announces Website Redesign

This May, Texas Tech Physicians announced the launch of its newly redesigned website. TTUHSC experts address a few questions about the new user experience.


TTUHSC’s Ahmed Investigating Cardiac Cell Regeneration

Mahmoud Salama Ahmed, Ph.D., and an international team of researchers have completed an investigation to uncover novel therapeutics or existing therapeutic regimens previously approved by the FDA for cardiac regeneration.